Chapter 3 - THE PATENT WAS WORTH MORE THAN THE COMPANY
Elias had spent seven years building a device called the Aster Array.
It began as a rehabilitation aid.
Then evolved into something larger.
A lightweight adaptive neuro-muscular interface that helped patients recovering from severe nerve injury regain controlled movement through personalized signal mapping.
It was not magic.
It did not cure paralysis.
It was not approved for broad clinical use yet.
But early trials were strong.
Three medical-device companies had already offered licensing deals.
The largest offer valued the core patent family at roughly $42 million.
Grant knew that number.
Everyone near Ward Adaptive Systems did.
What Grant did not know was that Elias rejected the most lucrative offer.
Why?
The buyer wanted exclusivity.
High margins.
Restricted hospital licensing.
Aggressive control over repair and replacement parts.
Elias hated the terms.
“This was built for people who already have expensive problems,” he told Mara once. “I’m not making access another one.”
Grant called that sentimental nonsense.
He wanted the sale.
Elias refused.
That argument split the brothers.
Officially, Grant remained chief commercial officer.
Unofficially, Elias stopped trusting him.
Mara had thought the break was about money.
Caleb told her it was worse.
“Elias believed Grant was negotiating behind his back.”
“With who?”
“Helixor Medical.”
The same company Elias rejected.
Caleb slid over emails.
Grant to a Helixor executive:
If Elias becomes unable to continue, control will shift.
Another:
There are succession paths.
Another:
Once the family position consolidates, we can reopen exclusivity.
Mara’s stomach turned.
“Family position?”
Caleb nodded.
“He thought he could get control after Elias died.”
“And in the old draft, he could.”
“Yes.”
“Why did Elias change it?”
Caleb looked at her.
“Because someone tried to buy Grant’s future interest before Elias was dead.”
Mara stared.
A private investment fund called Corven Ridge had offered Grant $6 million for an option tied to any patent rights he might inherit or control later.
Grant signed a preliminary agreement.
He was monetizing his brother’s death before it happened.
May you like
Elias found out.
Six weeks later, the trust changed.
